Abattis and Management Overcome Legal and Regulatory Allegations
March 19, 2021 09:00 ET
|
Abattis Bioceuticals Corp.
After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp....
Abattis Provides Update on Trading Halt and Corporate Developments
November 08, 2019 17:00 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments...
Abattis Completes Year End Audit and Provides Corporate Update
August 09, 2019 13:35 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial statements...
Abattis Announces Successful Closing of Pro Natura Acquisition
May 21, 2019 16:58 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, May 21, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release...
Abattis Provides Update on Conference Call
February 27, 2019 20:07 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) provides the following update on the Company’s recent...
Abattis Provides Update on Trading Halt and Announces Management Conference Call
February 18, 2019 11:00 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide the following update on the...
Abattis Removed From BCSC Temporary Order
January 17, 2019 08:27 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the...
Abattis Enters Into Definitive Share Exchange Agreement With NutriVida
January 10, 2019 22:44 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its new release...
Abattis Provides Marketing and Operational Updates
December 21, 2018 08:00 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce the launch of its new website and...
Comfort Launch by Vergence Naturals Exceeds Expectations
December 11, 2018 08:00 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an update on the recent soft-launch...